
    
      A Phase 2, Single-Center, Randomized, Double- Blind, Parallel-Group, Vehicle-Controlled Study
      Evaluating the Efficacy and Safety of AM001 Cream in the Treatment of Actinic Keratosis (AK)
      Lesions
    
  